2nd page - Jonathan S. Berek of the Stanford Cancer Institute, a member of the Ovarian Cancer Research Fund’s scientific advisory committee, is the principal investigator on a related trial of CVac. He said the drug “could be incorporated as a primary treatment” for ovarian cancer someday — ahead of surgery or chemotherapy. He said a similar vaccine has been shown to work well in men with relapsed prostate cancer.
Yet more links to provenge and dendreon. Looking forward to listing on the big N!
2nd page - Jonathan S. Berek of the Stanford Cancer Institute, a...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $482.9M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $313.9K | 939.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 135382 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 127690 | 13 |
View Market Depth
| Last trade - 11.29am 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |